{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T14:42:01Z","timestamp":1778337721174,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.contraception.2007.01.027","type":"journal-article","created":{"date-parts":[[2007,3,27]],"date-time":"2007-03-27T11:16:30Z","timestamp":1174994190000},"page":"430-437","source":"Crossref","is-referenced-by-count":55,"title":["Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen"],"prefix":"10.1016","volume":"75","author":[{"given":"R\u00e9gine L.","family":"Sitruk-Ware","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00ebl","family":"Menard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandana","family":"Rad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacobus","family":"Burggraaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marieke L.","family":"de Kam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara A.","family":"Tokay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irving","family":"Sivin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis","family":"Kluft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2007.01.027_bib1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0010-7824(90)90046-X","article-title":"Long-term contraception with the levonorgestrel 20 mcg\/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study","volume":"42","author":"Sivin","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.01.027_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00002018-200326050-00002","article-title":"Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants","volume":"26","author":"Sivin","year":"2003","journal-title":"Drug Saf"},{"key":"10.1016\/j.contraception.2007.01.027_bib3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0039-128X(00)00119-7","article-title":"Nestorone: a progestin with a unique pharmacological profile","volume":"65","author":"Kumar","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.contraception.2007.01.027_bib4","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0039-128X(03)00140-5","article-title":"Nestorone: clinical applications for contraception and HRT","volume":"68","author":"Sitruk-Ware","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.contraception.2007.01.027_bib5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0010-7824(00)00092-5","article-title":"Ovarian function during use of Nestorone(R) subdermal implants","volume":"61","author":"Brache","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.01.027_bib6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0010-7824(01)00199-8","article-title":"Ovarian function during use of vaginal rings delivering three different doses of Nestorone","volume":"63","author":"Brache","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.01.027_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.contraception.2004.12.015","article-title":"Serum Nestorone and ethinyl estradiol levels, and ovulation inhibition in women using three different dosage combinations of a Nestorone progestogen-ethinyl estradiol contraceptive vaginal ring on a bleeding-signaled regimen","volume":"72","author":"Fraser","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.01.027_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.contraception.2004.08.010","article-title":"Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial","volume":"71","author":"Sivin","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.01.027_bib9","series-title":"Guideline on clinical investigation of steroid contraceptives in women. Pre-authorization evaluation of medicines for human Use","first-page":"1","author":"Committee for Medicinal Products for Human Use (CHMP)","year":"2005"},{"key":"10.1016\/j.contraception.2007.01.027_bib10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/jech.52.12.775","article-title":"Combined oral contraceptives, smoking, and cardiovascular risk","volume":"52","author":"Farley","year":"1998","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.contraception.2007.01.027_bib11","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/bmj.321.7270.1190","article-title":"Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis","volume":"321","author":"Jick","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2007.01.027_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case-control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.01.027_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.105.171600","article-title":"Heart disease and stroke statistics \u2014 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"113","author":"Thom","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.contraception.2007.01.027_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0010-7824(01)00306-7","article-title":"Contraceptives and cerebral thrombosis: a five-year national case-control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.01.027_bib15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.94.3.483","article-title":"Prospective study of oral contraceptives and hypertension among women in the United States","volume":"94","author":"Chasan-Taber","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.contraception.2007.01.027_bib16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jama.284.1.72","article-title":"Ischemic stroke risk with oral contraceptives: a meta-analysis","volume":"284","author":"Gillum","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2007.01.027_bib17","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0140-6736(99)01734-1","article-title":"Importance of levonorgestrel dose in oral contraceptives for effects on coagulation","volume":"354","author":"Kluft","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2007.01.027_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1471-0528.1996.tb09716.x","article-title":"The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives","volume":"103","author":"Norris","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2007.01.027_bib19","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1055\/s-0038-1649849","article-title":"Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity","volume":"74","author":"Scarabin","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2007.01.027_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-2003-38334","article-title":"Venous and arterial thrombosis during oral contraceptive use: risks and risk factors","volume":"3","author":"Tanis","year":"2003","journal-title":"Semin Vasc Med"},{"key":"10.1016\/j.contraception.2007.01.027_bib21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2796.2001.00906.x","article-title":"Effect of second and third generation oral contraceptives on lipid metabolism in the absence or presence of the factor V Leiden mutation","volume":"250","author":"Kemmeren","year":"2001","journal-title":"J Intern Med"},{"key":"10.1016\/j.contraception.2007.01.027_bib22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-0037-1612973","article-title":"Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation","volume":"87","author":"Kemmeren","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2007.01.027_bib23","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1210\/endo.138.9.5404","article-title":"Androgen receptor-mediated antagonism of estrogen-dependent low density lipoprotein receptor transcription in cultured hepatocytes","volume":"138","author":"Croston","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.contraception.2007.01.027_bib24","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0002-9378(90)90584-T","article-title":"Effects of three combined oral contraceptive preparations containing desogestrel plus ethinyl estradiol on lipid metabolism in comparison with two levonorgestrel preparations","volume":"163","author":"Kloosterboer","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2007.01.027_bib25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.contraception.2004.01.004","article-title":"The combined contraceptive vaginal ring (NuvaRing) and lipid metabolism: a comparative study","volume":"69","author":"Tuppurainen","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.01.027_bib26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0010-7824(91)90069-R","article-title":"The pharmacokinetics of ethynylestradiol in the presence and absence of gestodene and desogestrel","volume":"43","author":"Orme","year":"1991","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.01.027_bib27","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.ajog.2005.02.067","article-title":"Effect of oral versus transdermal steroidal contraceptives on androgenic markers","volume":"192","author":"White","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2007.01.027_bib28","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1210\/endo-112-4-1188","article-title":"Synthesis and release of immunoreactive angiotensinogen by rat liver slices","volume":"112","author":"Clauser","year":"1983","journal-title":"Endocrinology"},{"key":"10.1016\/j.contraception.2007.01.027_bib29","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/09513590009167683","article-title":"Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers","volume":"14","author":"Oelkers","year":"2000","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.contraception.2007.01.027_bib30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0039-128X(96)00007-4","article-title":"Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure","volume":"61","author":"Oelkers","year":"1996","journal-title":"Steroids"},{"key":"10.1016\/j.contraception.2007.01.027_bib31","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1210\/jcem-43-5-1036","article-title":"Effects of ethinylestradiol on the renin-angiotensin-aldosterone-system and on plasma transcortin in women and men","volume":"43","author":"Oelkers","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2007.01.027_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00016348509157028","article-title":"Pharmacodynamic studies on desogestrel administered alone and in combination with ethinylestradiol","volume":"133","author":"Cullberg","year":"1985","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"key":"10.1016\/j.contraception.2007.01.027_bib33","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1210\/jcem-39-5-882","article-title":"Effects of progesterone and four synthetic progestagens on sodium balance and the renin-aldosterone system in man","volume":"39","author":"Oelkers","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2007.01.027_bib34","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1210\/jcem-62-3-536","article-title":"Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration","volume":"62","author":"De Lignieres","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2007.01.027_bib35","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(03)14066-4","article-title":"Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk","volume":"362","author":"Scarabin","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2007.01.027_bib36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajog.2005.12.007","article-title":"Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables","volume":"195","author":"Rad","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2007.01.027_bib37","first-page":"4331","article-title":"Influence of the M235T polymorphism of human angiotensinogen (AGT) on plasma AGT and renin concentrations after ethinylestradiol administration","volume":"85","author":"Azizi","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2007.01.027_bib38","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1210\/endo-90-2-422","article-title":"Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I","volume":"90","author":"Menard","year":"1972","journal-title":"Endocrinology"},{"key":"10.1016\/j.contraception.2007.01.027_bib39","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0002-9378(82)90218-6","article-title":"Comparison of pharmacodynamic properties of various estrogen formulations","volume":"144","author":"Mashchak","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2007.01.027_bib40","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0889-8545(21)00583-0","article-title":"Nonoral routes of estrogen administration","volume":"14","author":"Cedars","year":"1987","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.contraception.2007.01.027_bib41","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/0002-9378(85)90664-7","article-title":"Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol","volume":"151","author":"Goebelsmann","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2007.01.027_bib42","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1471-0528.1984.tb04747.x","article-title":"A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen","volume":"91","author":"Wilson","year":"1984","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2007.01.027_bib43","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/archinte.1970.00310100067006","article-title":"A possible mechanism for hypertension induced by oral contraceptives. Diminished feedback suppression of renin release","volume":"126","author":"Saruta","year":"1970","journal-title":"Arch Intern Med"},{"issue":"Suppl","key":"10.1016\/j.contraception.2007.01.027_bib44","first-page":"19","article-title":"Antimineralocorticoid activity of a novel oral contraceptive containing drospirenone, a unique progestogen resembling natural progesterone","volume":"7","author":"Oelkers","year":"2002","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2007.01.027_bib45","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1097\/00004872-199612000-00047","article-title":"Oral contraceptives and arterial stroke risk: the role of blood pressure","volume":"14","author":"Poulter","year":"1996","journal-title":"J Hypertens"},{"key":"10.1016\/j.contraception.2007.01.027_bib46","first-page":"179","article-title":"Transdermal contraceptive patch delivering norelgestromin and ethinyl estradiol. Effects on the lipid profile","volume":"48","author":"Creasy","year":"2003","journal-title":"J Reprod Med"},{"key":"10.1016\/j.contraception.2007.01.027_bib47","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0026-0495(99)90068-9","article-title":"Comparison of the effects of triphasic oral contraceptives with desogestrel or levonorgestrel on apolipoprotein A-I-containing high-density lipoprotein particles","volume":"48","author":"Cheung","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.contraception.2007.01.027_bib48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0010-7824(02)00436-5","article-title":"Effect of four different oral contraceptives on various sex hormones and serum-binding globulins","volume":"67","author":"Wiegratz","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.01.027_bib49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1067\/mob.2002.119179","article-title":"Different effects of oral contraceptives containing levonorgestrel or desogestrel on plasma lipoproteins and coagulation factor VII","volume":"186","author":"van Rooijen","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2007.01.027_bib50","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1067\/mob.2003.294","article-title":"A randomized controlled trial of second- versus third-generation oral contraceptives in the treatment of acne vulgaris","volume":"188","author":"Rosen","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2007.01.027_bib51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0010-7824(99)00093-1","article-title":"Effect of low-dose oral contraceptives on androgenic markers and acne","volume":"60","author":"Thorneycroft","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.01.027_bib52","first-page":"123","article-title":"Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment","volume":"74","author":"Thorneycroft","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.contraception.2007.01.027_bib53","first-page":"755","article-title":"Effects of biphasic oral contraceptives containing desogestrel (Oilezz) on cycle control facial acne and seborrhea in healthy Thai women","volume":"89","author":"Wonglikhitpanya","year":"2006","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.contraception.2007.01.027_bib54","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9378(03)00950-5","article-title":"Sex hormone-binding globulin \u2014 a surrogate marker for the prothrombotic effects of combined oral contraceptives","volume":"190","author":"van Rooijen","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2007.01.027_bib55","first-page":"482","article-title":"Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?","volume":"81","author":"Odlind","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2007.01.027_bib56","series-title":"Combined oral contraceptives and venous thromboembolism. CPMP Public Assessment Report","first-page":"1","author":"Committee for Proprietary Medicinal Products (CPMP)","year":"2001"},{"key":"10.1016\/j.contraception.2007.01.027_bib57","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2165\/00002018-200427130-00003","article-title":"Safety of a new oral contraceptive containing drospirenone","volume":"27","author":"Heinemann","year":"2004","journal-title":"Drug Saf"},{"key":"10.1016\/j.contraception.2007.01.027_bib58","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S1701-2163(16)30342-5","article-title":"Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation","volume":"25","author":"Spitzer","year":"2003","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.contraception.2007.01.027_bib59","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jacc.2004.02.001","article-title":"Evidence-based guidelines for cardiovascular disease prevention in women","volume":"43","author":"Mosca","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.contraception.2007.01.027_bib60","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1185\/030079905X43677","article-title":"Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel","volume":"21","author":"Shepherd","year":"2005","journal-title":"Curr Med Res Opin"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782407000881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782407000881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T20:48:04Z","timestamp":1628714884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782407000881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0010782407000881"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2007.01.027","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}